Myomo (MYO) Operating Margin Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 241.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2,446.00 |
| Jun 30, 2025 | -3,273.00 |
| Mar 31, 2025 | 6,777.00 |
| Dec 31, 2024 | 4,912.00 |
| Sep 30, 2024 | 2,945.00 |
| Jun 30, 2024 | 368.00 |
| Mar 31, 2024 | -2,609.00 |
| Dec 31, 2023 | 401.00 |
| Sep 30, 2023 | 3,118.00 |
| Jun 30, 2023 | 6,023.00 |
| Mar 31, 2023 | -669.00 |
| Dec 31, 2022 | 1,195.00 |
| Sep 30, 2022 | -2,472.00 |
| Jun 30, 2022 | 500.00 |
| Mar 31, 2022 | 5,470.00 |
| Dec 31, 2021 | -2,261.00 |
| Sep 30, 2021 | 8,579.00 |
| Jun 30, 2021 | 24,803.00 |
| Mar 31, 2021 | 21,397.00 |
| Dec 31, 2020 | 12,521.00 |
| Sep 30, 2020 | 33,360.00 |
| Jun 30, 2020 | -2,435.00 |
| Mar 31, 2020 | -1,628.00 |
| Dec 31, 2019 | 13,774.00 |
| Sep 30, 2019 | -2,096.00 |
| Jun 30, 2019 | 11,671.00 |
| Mar 31, 2019 | 44,406.00 |
| Dec 31, 2018 | 203,156.00 |
| Sep 30, 2018 | -15,102.00 |
| Jun 30, 2018 | 20,631.00 |
| Mar 31, 2018 | 660,403.00 |
| Dec 31, 2017 | -209,420.00 |
| Sep 30, 2017 | 21,325.00 |
| Jun 30, 2017 | -35,942.00 |